APR 08, 2015 09:16 AM PDT

Turbo-Charging Hormone Can Regrow the Heart

WRITTEN BY: Judy O'Rourke
Researchers have discovered a way to stimulate muscle regrowth in the heart of a mouse, opening up prospects of new treatments for many who suffer heart attacks each year.

The animal study found it was possible to regenerate muscle cell numbers in the heart by up to 45 percent by ‘turbo-charging' a hormone that helped coordinate cell growth.

According to study lead author, associate professor Richard Harvey, PhD, UNSW, based at the Victor Chang Cardiac Research Institute, New South Wales, Australia, this is an important step toward repairing a broken heart.

"Unlike blood, hair, or skin cells, which can renew themselves throughout life, cell division in the heart virtually comes to a standstill shortly after birth, which means the heart can't fully regenerate if it is damaged later in life," Harvey says.

"Previous studies have demonstrated that it is possible to coax heart muscle cells to proliferate again, but only at very trivial levels," he says. "What the research team has been able to do is boost heart muscle cell numbers by as much as 45 percent after a heart attack."

The scientists focused on a signalling system in the heart driven by a hormone called ‘neuregulin'.

By switching the neuregulin pathway to ‘turbo charge', the researchers found that heart muscle cells continued to divide in a spectacular way in both the adolescent and adult periods. Stimulating the neuregulin pathway during a heart attack led to replacement of lost muscle.

"This big achievement will focus the attention of the field on heart muscle cell replacement as a therapeutic option for ischemic heart disease," Harvey says. "The dream is that one day we will be able to regenerate damaged heart tissue, much like a salamander can regrow a new limb if it is bitten off by a predator. Just imagine if the heart could learn to regrow and heal itself. That would be the ultimate prize."

The research, conducted at the Weizmann Institute of Science in collaboration with the Victor Chang Cardiac Research Institute, and titled "ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation," is published in Nature Cell Biology.

[Source: UNSW]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
AUG 19, 2019
Cardiology
AUG 19, 2019
Blood Test For Atherosclerosis May Be On The Horizon
A pilot project from Duke Health suggests that a blood test for atherosclerosis may be on the horizon. Atherosclerosis is the accumulation of fatty deposit...
AUG 19, 2019
Cardiology
AUG 19, 2019
Cardiovascular Risks Linked To Excessive Weight In Infancy
New research, from the University of Sydney, found excessive weight gain in children under two can lead to cardiovascular risk factors in teenage years.&nb...
AUG 19, 2019
Cardiology
AUG 19, 2019
Is High Intensity Interval Training Appropriate for Heart Patients
High-Intensity Interval Training, or HIIT, is a form of cardiovascular interval training that uses short bursts of near-maximal intensity exercise alternat...
AUG 19, 2019
Cardiology
AUG 19, 2019
How Is Cardiovascular Rehabilitation Failing Woman
For woman across North America, cardiovascular disease (CVD) remains a leading cause of death. Evidence strongly suggests that CVD risk factors such as poo...
AUG 19, 2019
Cardiology
AUG 19, 2019
Helping Hearts Heal After Cardiac Events With Stem Cells
Heart disease kills more people worldwide than any other cause. In America, it is the number one reason people are admitted to the hospital. Additionally, ...
AUG 19, 2019
Cardiology
AUG 19, 2019
New Noninvasive Method For Controlling Atrial Fibrillation
Atrial fibrillation or Afib is a condition in which the heartbeat is irregular. Often the pulse is rapid in Afib patients as the heart attempts to maintain...
Loading Comments...